Free Trial

Annexon (ANNX) SEC Filings & 10K Form

Annexon logo
$6.12 -0.21 (-3.32%)
(As of 11/15/2024 ET)

Recent Annexon SEC Filings

DateFilerForm TypeView
11/14/2024
6:21 PM
Annexon (Subject)
BB BIOTECH AG (Filed by)
Form SC 13G/A
11/14/2024
5:46 PM
Annexon (Subject)
Logos Global Management LP (Filed by)
Form SC 13G/A
11/12/2024
8:38 AM
Adage Capital Management, L.P. (Filed by)
Annexon (Subject)
Form SC 13G/A
11/08/2024
1:17 PM
Annexon (Subject)
BlackRock, Inc. (Filed by)
Form SC 13G
11/01/2024
3:15 PM
Annexon (Issuer)
Love Douglas (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
10/22/2024
5:06 PM
Annexon (Subject)
BlackRock, Inc. (Filed by)
Form SC 13G
10/21/2024
7:15 PM
Annexon (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
10/17/2024
4:09 PM
Annexon (Issuer)
Yednock Ted (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
10/15/2024
1:03 PM
Annexon (Subject)
Yednock Ted (Reporting)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
09/27/2024
7:01 AM
Annexon (Filer)
Form S-8
Registration statement under Securities Act of 1933 to be offered to employees pursuant to certain plans  
09/20/2024
3:30 PM
Annexon (Issuer)
Yednock Ted (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
09/19/2024
11:32 AM
Annexon (Subject)
Yednock Ted (Reporting)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
09/16/2024
3:30 PM
Annexon (Issuer)
Yednock Ted (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
09/12/2024
9:24 AM
Annexon (Subject)
Yednock Ted (Reporting)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
09/06/2024
3:30 PM
Annexon (Issuer)
Yednock Ted (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
09/05/2024
9:15 AM
Annexon (Subject)
Yednock Ted (Reporting)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
09/04/2024
3:34 PM
Annexon (Issuer)
Carson William H. (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
08/30/2024
5:00 PM
Annexon (Issuer)
Yednock Ted (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
08/29/2024
1:08 PM
Annexon (Subject)
Yednock Ted (Reporting)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
08/15/2024
11:15 PM
Annexon (Filer)
Form EFFECT
08/12/2024
3:59 PM
Annexon (Filer)
Form S-3
Registration statement under Securities Act of 1933  
08/12/2024
7:05 AM
Annexon (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
08/05/2024
6:53 PM
Annexon (Issuer)
Carson William H. (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
08/05/2024
7:11 AM
Annexon (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
07/17/2024
3:46 PM
Annexon (Issuer)
Yednock Ted (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
07/17/2024
3:48 PM
Annexon (Issuer)
Lew Jennifer (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
07/17/2024
3:49 PM
Annexon (Issuer)
Overdorf Michael (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
07/15/2024
2:38 PM
Annexon (Subject)
Overdorf Michael (Reporting)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
07/15/2024
2:24 PM
Annexon (Subject)
Lew Jennifer (Reporting)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
07/15/2024
2:25 PM
Annexon (Subject)
Yednock Ted (Reporting)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
07/02/2024
4:43 PM
Annexon (Issuer)
Carson William H. (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
06/25/2024
4:14 PM
Annexon (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
06/12/2024
11:28 AM
Annexon (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
06/07/2024
8:41 PM
Annexon (Issuer)
Carson William H. (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
06/07/2024
8:42 PM
Annexon (Issuer)
Waddill William D. (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
06/07/2024
8:43 PM
Annexon (Issuer)
Choi Jung (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
06/07/2024
8:44 PM
Annexon (Issuer)
Satter Muneer A (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
06/07/2024
8:45 PM
Annexon (Issuer)
WIGGANS THOMAS G (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
06/07/2024
8:40 PM
Annexon (Issuer)
Cockroft Bettina M. (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
06/07/2024
3:42 PM
Annexon (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
06/06/2024
8:57 PM
Annexon (Filer)
Form 424B5
Buffett’s Selling Out: Is Your 401(k) About to Get Wiped Out? (Ad)

Let me share something important with you. Just a few weeks ago, Warren Buffett unloaded $932 million worth of bank stocks. He didn't do it on a whim—he knows something big is coming. The question is: Why aren't you taking action, too?

06/05/2024
3:23 PM
Annexon (Issuer)
Carson William H. (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
06/04/2024
4:21 PM
Annexon (Filer)
Form 424B5
06/04/2024
6:05 AM
Annexon (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
04/22/2024
7:35 PM
Annexon (Subject)
BB BIOTECH AG (Filed by)
Form SC 13G
04/10/2024
6:17 PM
Annexon (Issuer)
Carson William H. (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
04/01/2024
11:15 PM
Annexon (Filer)
Form EFFECT
03/26/2024
4:01 PM
Annexon (Filer)
Form S-8
Registration statement under Securities Act of 1933 to be offered to employees pursuant to certain plans  
03/26/2024
4:05 PM
Annexon (Filer)
Form S-3
Registration statement under Securities Act of 1933  
03/26/2024
3:05 PM
Annexon (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
03/26/2024
3:10 PM
Annexon (Filer)
Form 10-K
Annual report pursuant to Section 13 or 15(d)  
02/20/2024
2:12 PM
Annexon (Subject)
Overdorf Michael (Reporting)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
02/20/2024
2:12 PM
Annexon (Subject)
Lew Jennifer (Reporting)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
02/20/2024
2:15 PM
Annexon (Subject)
Yednock Ted (Reporting)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
02/14/2024
7:46 PM
Annexon (Subject)
Venrock Healthcare Capital Partners II, L.P. (Filed by)
Form SC 13G/A
02/14/2024
6:56 PM
Annexon (Issuer)
Love Douglas (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
02/14/2024
6:59 PM
Annexon (Issuer)
Overdorf Michael (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
02/14/2024
6:52 PM
Annexon (Issuer)
Yednock Ted (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
02/14/2024
6:54 PM
Annexon (Issuer)
Lew Jennifer (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
02/14/2024
2:45 PM
Annexon (Subject)
Fairmount Funds Management LLC (Filed by)
Form SC 13G/A
02/14/2024
11:43 AM
Annexon (Subject)
EVENTIDE ASSET MANAGEMENT, LLC (Filed by)
Form SC 13G/A
02/14/2024
9:26 AM
Annexon (Subject)
BIOTECHNOLOGY VALUE FUND L P (Filed by)
Form SC 13G/A
02/13/2024
6:23 PM
Annexon (Subject)
Logos Global Management LP (Filed by)
Form SC 13G/A
02/13/2024
5:57 PM
Annexon (Subject)
Bain Capital Life Sciences Fund, L.P. (Filed by)
Form SC 13G/A
02/12/2024
2:39 PM
Annexon (Subject)
Yednock Ted (Reporting)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
02/12/2024
2:40 PM
Annexon (Subject)
Lew Jennifer (Reporting)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
02/12/2024
2:41 PM
Annexon (Subject)
Love Douglas (Reporting)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
02/12/2024
2:45 PM
Annexon (Subject)
Overdorf Michael (Reporting)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
02/07/2024
6:02 AM
ADAGE CAPITAL PARTNERS GP, L.L.C. (Filed by)
Annexon (Subject)
Form SC 13G/A
01/23/2024
3:57 PM
Annexon (Issuer)
Lew Jennifer (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
01/23/2024
3:58 PM
Annexon (Issuer)
Overdorf Michael (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
01/10/2024
7:53 AM
Annexon (Subject)
FMR LLC (Filed by)
Form SC 13G
12/29/2023
3:12 PM
Annexon (Issuer)
Yednock Ted (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
12/28/2023
3:30 PM
Annexon (Issuer)
Annexon (Issuer)
Satter Muneer A (Reporting)
Satter Muneer A (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
12/27/2023
3:50 PM
Annexon (Subject)
Yednock Ted (Reporting)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
12/22/2023
4:28 PM
Annexon (Filer)
Form 8-K/A
12/20/2023
4:17 PM
Annexon (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
12/20/2023
4:24 PM
Annexon (Subject)
Form FWP
(Data available from 1/1/2016 forward)


Related Companies and Tools


This page (NASDAQ:ANNX) was last updated on 11/17/2024 by MarketBeat.com Staff
From Our Partners